GSK Investigational Site
Webster, Texas 77598-4420
1 studies enrolling now · 13 studies all time
What they study most
BRCA1 Gene Mutation, BRCA2 Gene Mutation, Bowel Dysfunction, Cancer, Carcinoma of Breast, Constipation, Dermatitis, Atopic, Herpes Simplex Infection, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Infections, Papillomavirus, Neoplasms, Breast, Ovarian Neoplasms
Studies at this site
- Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2) — Recruiting now
- Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level — Completed
- Belimumab Assessment of Safety in SLE — Completed
- A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients — Stopped early
- HerpeVac Trial for Young Women — Completed
- Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18 — Completed
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US — Completed
- A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector — Completed
- A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD) — Completed
- A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis — Completed
- Fluticasone Propionate/Salmeterol Combination 250/50 DISKUS in the Exercise Endurance Time in Patients With Chronic Obstructive Pulmonary Disease — Completed
- Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication — Completed
- Randomized Discontinuation Study of Lapatinib Versus Placebo in Subjects With Documented Tumor Progression After Chemotherapy, or Where no Approved Therapy Exists — Stopped early